In its 98th episode of the year, "This Week in Virology" (TWiV) has released episode 1285, offering a comprehensive review…
Read More
TWiV 1285: Encapsidating Viruses 2025
Breakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Offers New Therapeutic Pathways
In a significant advancement for the field of oncology, a collaborative study led by investigators at the Johns Hopkins Kimmel…
Read More
Rethinking evidence generation for ultra-rare diseases
Developing treatments for ultra-rare diseases presents fundamental challenges for traditional evidence generation, necessitating a paradigm shift in how scientific rigor…
Read More
Molecular Switch in Brain Immune Cells Identified as Potential Driver of Alzheimer’s Disease Progression
In a significant advancement for neurobiology, researchers at Scripps Research have uncovered a specific molecular mechanism that triggers chronic brain…
Read More
Revolutionary Solar-Powered Desalination Technology Offers a Sustainable Path to Global Clean Water Access and Critical Mineral Recovery
The United Nations recently reported a sobering statistic that highlights a burgeoning humanitarian crisis: approximately 2.2 billion people across the…
Read More
Expanding Screenings for Type 1 Diabetes Reveals a Wider Burden Than Previously Understood
A paradigm shift in the approach to identifying type 1 diabetes (T1D) is being advocated, as new research suggests that…
Read More
The Liver’s Magnetic Secret: Pigeons’ Astonishing Navigation Revealed Through Specialized Immune Cells
The astonishing ability of homing pigeons to traverse hundreds, even thousands, of miles and unerringly find their way back to…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin
In a recent clinical update hosted by This Week in Virology (TWiV), Dr. Daniel Griffin and Vincent Racaniello expressed profound…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Assisted Weight Management
The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), has transformed…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More